Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Evaluation of SCALE PET Software for Quantitative Brain PET Analysis in Alzheimer's Disease [NA]
The clinical trial evaluating SCALE PET software for quantitative brain PET analysis in Alzheimer's disease and mild cognitive impairment ha…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease [Phase 2]
Phase 2 study of JNJ-64042056 in preclinical Alzheimer's disease is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Effectiveness of Genistein in Mild Cognitive Impairment [NA]
A clinical trial evaluates the effectiveness of genistein in mild cognitive impairment and Alzheimer's disease; the study is sponsored by Un…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Investigating the Impact of Duration and Amount of Light on the Circadian System Response - Aim 3 [NA]
The trial update reports the completion of a study examining how the duration and amount of light influence circadian system responses in co…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Comparing Structured Retrieval Practice and Reading-Based Education for Dementia Caregivers [NA]
A clinical trial comparing structured retrieval practice versus reading-based education for dementia caregivers is currently recruiting, spo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)
Update on the BASIC-Cognitive clinical trial led by the University of Michigan, studying cognitive outcomes in dementia populations (Alzheim…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: TRIAD - Tracking Risk in Integrated Alzheimer's Diagnostics.
The TRIAD study (Tracking Risk in Integrated Alzheimer's Diagnostics) is currently recruiting to evaluate integrated diagnostics for cogniti…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: VR Pupillometry in Cognitive Impairment
A clinical trial update announcing a recruiting study on virtual reality pupillometry for cognitive impairment, including Alzheimer's diseas…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating potential disease-modifying treatments for early-onset Alzheimer's disease caused by a genetic muta…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial of nilotinib in mild-to-moderate Alzheimer's disease has completed. The update summarizes safety, biomarker data, and clinical…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) [Phase 2, Phase 3]
Clinical trial update for the DIAN-TU study, investigating disease-modifying therapies in individuals with dominantly inherited early-onset …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 [Phase 2, Phase 3]
DIAN-TU-001 is a master protocol investigating potential disease-modifying treatments for dominantly inherited Alzheimer's disease in indivi…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study of AMDX-2011P in Participants With Alzheimer's Disease [Phase 2]
Phase 2 trial AMDX-2011P in Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Validation of a Digital Intervention to Rehabilitate Cognitive Resources [NA]
A clinical trial is validating a digital intervention designed to rehabilitate cognitive resources in people with mild cognitive impairment …
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Supporting Our Caregivers In ADRD Learning (SOCIAL) [NA]
This is a completed clinical trial update from Massachusetts General Hospital on a caregiver support program for Alzheimer's disease and rel…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Assessment of Informal Support Provided by Caregivers at Different Stages of Alzheimer's Disease
This clinical trial update describes an ongoing study evaluating informal caregiver support across Alzheimer's disease stages; the trial is …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation [Phase 2, Phase 3]
An ongoing Phase 2/3 clinical trial evaluating a potential disease-modifying treatment for individuals at risk for or with early-onset Alzhe…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease: Implementation Phase 2 [NA]
The trial update reports the completion of Phase 2 implementation of a program aimed at reducing inappropriate medication use among older ad…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluating the safety and potential modulation of microglial activation by foralumab in Alzheimer's disease-related…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Early Onset Alzheimer's Disease Genomic Study
A genomic study focused on early-onset Alzheimer’s disease has completed. The sponsor is Baylor Research Institute.
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Improving Mental Health for Care Partners of Persons With AD/ADRD [NA]
Clinical trial evaluating an intervention to improve mental health for caregivers of people with Alzheimer's disease and related dementias i…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Attenuation of Postprandial Inflammatory Processes in Alzheimer's Disease Patients by Consumption of Pomace Oil [NA]
An active, not-recruiting clinical trial is evaluating whether pomace oil can attenuate postprandial inflammation in individuals with Alzhei…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Evaluating the Efficacy of the Pain Identification and Communication Toolkit [NA]
Weill Medical College of Cornell University is recruiting for a study evaluating a Pain Identification and Communication Toolkit for individ…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Decision Making and Implementation of Aging-in-Place/Long Term Care Plans Among Older Adults [NA]
This completed clinical trial from Northwestern University examines decision making and implementation of aging-in-place and long-term care …
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease [Phase 2]
This document reports an ongoing Phase 2 clinical trial evaluating E2814 in combination with lecanemab in people with early Alzheimer's dise…